Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.52 -0.02 (-1.30%)
As of: Nov 11, 2026 · 3:58 PM EST

Zhengye Biotechnology Holding (ZYBT) Total Current Liabilities (2023 - 2025)

Updated

Zhengye Biotechnology Holding's Total Current Liabilities was $16.99 million in the quarter ended Dec 31, 2025, down 10.2% from $18.92 million a year earlier.

Analysis

Zhengye Biotechnology Holding (ZYBT) Total Current Liabilities (2023 - 2025) Analysis & Trends

As of Dec 31, 2025, Total Current Liabilities at Zhengye Biotechnology Holding came in at $17.23 million, down 7.5% from the prior year.

  • In earlier years, Total Current Liabilities was $18.62 million in the year ended Dec 31, 2024 (-12.4%) and $21.26 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 47.00 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 55.46 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 43.10 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 28.80 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -31.27 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 23.23 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 12.00 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 31.73 Bn
10 Zhengye Biotechnology Holding 72.98 Mn 69.39 Mn - 17.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 17.22 Mn
Jun 30, 2025 18.82 Mn
Dec 31, 2024 18.62 Mn
Dec 31, 2023 21.14 Mn
API Access

Zhengye Biotechnology Holding Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ZYBT&period=max&api_key=YOUR_API_KEY